After a blistering 67% rally over the past 12 months, Goldman Sachs shares are trading near $926. But with valuation models suggesting the stock is roughly fairly priced, investors are split on whether the best gains are behind them — or just getting started.
Goldman Sachs (GS) is back on investors' radar after a mixed week of trading, closing at $925.87. With $61.53 billion in revenue and a strong three-year shareholder return of roughly 21x, the question is whether the stock still offers value — or if the market has already priced in the next chapter of growth.
With Apple expected to enter the foldable phone market as early as September, Barclays sees a buying opportunity in two overlooked chipmakers: Skyworks Solutions and Qorvo.
When the Google parent reports earnings on Wednesday, these will be the two most important metrics to watch.
The pharma giant’s yield has climbed as its stock stumbled. Here’s what investors need to weigh.
RS Technologies (TSE:3445) has surged 68% in the past month, drawing fresh attention after an April 24 board meeting to consider restricted stock compensation. With earnings due May 14 and a P/E of 17.4x — below both its peers and the broader Japanese semiconductor sector — the stock looks undervalued on one metric, but a DCF model suggests it may be overpriced. We break down the mixed signals, the wafer reclamation tailwind, and what investors should watch next.
Cognex shares have more than doubled over the past year, but a closer look at valuation metrics suggests the stock may be running ahead of fundamentals. With a DCF-based fair value estimate of just $38.37 per share, some analysts and investors are questioning whether the current price of $62.26 leaves room for further gains — or sets the stage for a correction.
Rep. Daniel Meuser has consistently sold shares of the AI chipmaker Nvidia since 2022, a strategy that has cost him potential profits exceeding 630% as the stock soared. The trades, some executed by his spouse, renew scrutiny over congressional stock activity and timing.
The CFO of this power semiconductor firm unloaded over 8,000 shares amid a massive rally. But the sale was pre-planned, and insiders still hold big positions.
John Ternus will take over as Apple's new CEO on September 1, raising questions about the company's future direction and stock performance.
The semiconductor testing equipment maker posted a beat on Q1 earnings and issued upbeat guidance, but investors cashed out on valuation concerns, sending shares down more than 11% for the week.
Shares of Pfizer have fallen more than 50% since their 2021 high, but with a dividend yield of 6.4%, some investors are asking whether the pharma giant is a value trap or a long-term opportunity.
Plug Power shares have surged over the past year, but the stock remains below $3. A closer look at its history of dilution and profitability challenges suggests the road to $30 is anything but certain.
A good business doesn't always make a good stock. Palantir’s latest numbers were impressive, but its valuation remains a towering concern.
For the first time in nearly two years, Berkshire Hathaway repurchased $234 million of its own shares. It’s a small buyback, but the signal behind it could be huge for investors watching the conglomerate’s next move.
Glynn Capital Management sold its entire Klaviyo stake in Q1 2026, avoiding a brutal post-earnings selloff. But the move raises questions about what smart money saw coming.
After a multi-year run that saw shares climb nearly 200% in five years, AAR now trades at roughly US$117.82. But a DCF analysis suggests the stock may be significantly overvalued, while P/E comparisons paint a more moderate picture. Investors are split on whether the aerospace and defense services provider still has room to run.
Aveanna Healthcare delivers home-based nursing and therapy services nationwide, with a focus on medically complex pediatric and adult care.
The enterprise software firm turned Bitcoin behemoth is pivoting its funding strategy, promoting new perpetual preferred stock to navigate volatility and a steep discount to its crypto holdings' value.
As shares of eVTOL pioneer Archer Aviation hover around $7, investors are weighing its multi-trillion dollar market potential against its pre-revenue status and speculative trading patterns.
